Hedge Fund - Saba Capital

Boaz Weinstein Bio, Returns, AUM, Net Worth

Saba Capital Management, L.P. is an investment adviser founded in 2009. It originated as a spin-out from "Saba Principal Strategies," one of the largest proprietary trading groups in the industry, established by Boaz Weinstein at Deutsche Bank in 1998. Saba's senior members, who have worked together for over a decade, are renowned for pioneering credit relative value and capital structure trading strategies.

Boaz Weinstein is the Founder and Chief Investment Officer of Saba Capital Management, a $4.8 billion hedge fund focused on credit relative value strategies, based in New York City. He established Saba in 2009 as a spin-off from the Deutsche Bank proprietary credit trading group he founded in 1998. At Saba, Mr. Weinstein leads a team of 52 professionals, with the senior members having worked together for over a decade. In 2021, Risk.net was named Saba Capital Management Hedge Fund of the Year. Mr. Weinstein spent eleven years at Deutsche Bank, achieving the title of Managing Director at age 27 and eventually serving as Co-Head of Global Credit Trading, overseeing 650 investment professionals and contributing to the Global Markets Executive Committee. He graduated from the University of Michigan, Ann Arbor, with a BA in Philosophy and became a National Master in chess at age 16.

Saba Capital Management is a hedge fund managing discretionary assets of $13,424,813,328 for 37 clients, as reported in their Form ADV dated March 2024. Their Q1 2024 13F filing included $5,839,030,433 in managed 13F securities, with a top 10 holdings concentration of 53.67%. The firm's largest holding is the iShares Russell 2000 ETF, with 4,592,900 shares.

Boaz Weinstein
Fund Profile
Filing Period:
Fund Name: Saba Capital
Manager Boaz Weinstein
Portfolio Value $5,839,030,433
Change This QTR +1.17%
Filing Period:
Last update:
No. Security Ticker Shares Value Activity % Port History
1. IEF 4,592,900 $965,886,870 +6838% 16.54%
2. ECAT 28,496,747 $494,703,528 +19% 8.47%
Blackrock Innovation And Grw
51,963,968 $422,986,700 +19% 7.24%
Blackrock Health Sciences Te
20,492,010 $335,864,044 +23% 5.75%
Blackrock Cap Allocation Ter
16,333,600 $272,117,776 +20% 4.66%
News, Interviews and Investor Letters